文献速递其他结缔组织病

EPSTI1升高通过NF-κB信号促进原发性干燥综合征B细胞过度活化

Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome.
PubMed 文献 · Ann Rheum Dis · 2020-02-29

该研究对3例原发性干燥综合征(pSS)患者和3例健康对照的B细胞进行全转录组测序,发现77个上调、32个下调的差异表达基因,并在40例pSS和40例健康对照的B细胞中证实EPSTI1表达显著升高。机制上,EPSTI1通过促进IκBα降解增强p65磷酸化和NF-κB信号活化,从而促进TLR9信号介导的B细胞增殖和免疫球蛋白产生,提示EPSTI1是pSS潜在治疗靶点。

要点

  • pSS患者B细胞中EPSTI1表达显著高于健康对照。
  • 沉默EPSTI1可降低CpG刺激的B细胞增殖及IgG、IgM产生。
  • EPSTI1通过促进IκBα降解增强NF-κB信号活化。

核心结论

  • pSS患者B细胞中EPSTI1表达升高,通过促进IκBα降解增强p65磷酸化和NF-κB信号活化,进而促进TLR9信号介导的B细胞过度活化,提示EPSTI1是pSS潜在治疗靶点。

研究设计与样本

  • 对3例pSS患者和3例匹配健康对照的B细胞进行全转录组测序。
  • 在40例pSS患者和40例健康对照的B细胞中用定量PCR和western blot验证差异表达基因。
  • 用siRNA或质粒转染B细胞,以CpG或抗IgM刺激后检测增殖能力和免疫球蛋白产生。

主要发现

  • pSS患者B细胞中鉴定出77个上调基因和32个下调基因。
  • pSS患者B细胞中EPSTI1表达显著高于健康对照。
  • CpG刺激下,沉默EPSTI1的B细胞较对照B细胞增殖减少、IgG和IgM产生降低。
  • 沉默EPSTI1的B细胞p-p65水平降低、IκBα水平升高;过表达EPSTI1的B细胞p-p65水平升高、IκBα水平降低。
  • IκBα降解抑制剂Dehydrocostus Lactone处理可减弱EPSTI1促进的p65磷酸化。

临床怎么用

  • EPSTI1可能作为pSS中B细胞过度活化的生物标志物或治疗靶点进行进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterised by aberrant B cell hyperactivation, whose mechanism is partially understood. METHODS: We performed whole transcriptome sequencing of B cells from three pSS patients and three matched healthy controls (HC). Differentially expression genes (DEGs) were confirmed with B cells from 40 pSS patients and 40 HC by quantitative PCR and western blot. We measured the proliferation potential and immunoglobulins production of siRNA-transfected or plasmid-transfected B cells stimulated with cytosine-phosphate-guanine (CpG) or anti-IgM. We also explored Toll-like receptor 9 (TLR9) signalling to reveal the potential mechanism of B cell hyperactivation in pSS. RESULTS: We identified 77 upregulated and 32 downregulated DEGs in pSS B cells. We confirmed that epithelial stromal interaction (EPST1) expression in pSS B cells was significantly higher than that from HCs. EPSTI1-silencing B cells stimulated with CpG were less proliferated and produced lower level of IgG and IgM comparing with control B cells. EPSTI1-silencing B cells expressed lower level of p-p65 and higher level of IκBα, and B cells with overexpressed EPSTI1 showed higher level of p-p65 and lower level of IκBα. Finally, IκBα degradation inhibitor Dehydrocostus Lactone treatment attenuated p65 phosphorylation promoted by EPSTI1. CONCLUSION: Elevated EPSTI1 expression in pSS B cells promoted TLR9 signalling activation and contributed to the abnormal B cell activation, which was promoted by facilitating p65 phosphorylation and activation of NF-κB signalling via promoting IκBα degradation. EPSTI1 might be implicated in pSS pathogenesis and was a potential therapeutic target of pSS.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Sun JL, Zhang HZ, Liu SY, et al. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome. Ann Rheum Dis. 2020. PMID: 32114510. doi:10.1136/annrheumdis-2019-216428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。